Company Filing History:
Years Active: 2021
Title: Michael Anthony Marino: Innovator in Cannabinoid Detection
Introduction
Michael Anthony Marino is a notable inventor based in North Bellmore, NY (US). He has made significant contributions to the field of cannabinoid detection through his innovative patent. His work focuses on the detection, identification, and quantification of synthetic indole and indazole cannabinoids, which are increasingly relevant in today's society.
Latest Patents
Marino holds a patent for a method titled "Nuclear magnetic resonance implemented synthetic indole and indazole cannabinoid detection, identification, and quantification." This invention provides a novel approach for detecting synthetic cannabinoids in a sample without the need for chromatography. The method involves adding a deuterated solvent to a solid sample to create a suspension. The presence of synthetic cannabinoids is determined by analyzing the NMR spectrum of the sample. Specifically, one-dimensional proton NMR can identify peaks between 8.00 and 8.50 ppm and between 4.00 and 4.40 ppm, indicating the presence of synthetic indole or indazole cannabinoids. Additionally, two-dimensional Correlation Spectroscopy (COSY) NMR can detect spots between 6.50 and 9.00 ppm and between 1.50 and 4.50 ppm for the same purpose.
Career Highlights
Michael Anthony Marino is affiliated with Hofstra University, where he contributes to research and innovation in cannabinoid detection. His work is crucial in advancing the understanding and identification of synthetic cannabinoids, which have implications for public health and safety.
Collaborations
Marino collaborates with colleagues such as Ling Ling Huang and Brandy Voyer, who share his commitment to advancing research in this important field.
Conclusion
Michael Anthony Marino's innovative work in cannabinoid detection exemplifies the impact of scientific research on contemporary issues. His patent represents a significant advancement in the field, providing a reliable method for identifying synthetic cannabinoids.